Skip to content

Released Nov 5, 2025, after the close

10-Q filed Nov 6, 2025, 37 days after period end · 0001653477-25-000127

Q3 2025 · 10-Q
Revenue$333.10M−0.2% vs Q3 2024+0.5% vs Q2 2025
Net Income$43.50MN/M vs Q3 2024N/M vs Q2 2025
EPS Diluted$1.18N/M vs Q3 2024N/M vs Q2 2025
Gross Profit$133,900,000+1.7%
Operating Cash Flowderived$129,700,000+178.9%
Free Cash Flowderived$117,800,000+313.3%
Margins · derived
Gross margin40.2%+0.8 pt vs Q3 2024
Net margin13.1%+45.2 pt vs Q3 2024

What the release said

The release

Same quarter

MetricQ3 2025Q3 2024Q3 2023Q3 2022
Revenue$333.10M$333.80M$446.00M$482.00M
Net Income$43.50M-$107.20M$25.20M$75.40M
EPS Diluted$1.18-$2.94$0.69$1.98

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR